Core Viewpoint - The market experienced a correction last week, but certain stocks within the brand index showed resilience, indicating potential investment opportunities in sectors like electronics, new energy, new consumption, and real estate as uncertainties ease [1][4]. Market Performance - The market indices saw declines: Shanghai Composite Index down 1.47%, Shenzhen Component down 4.99%, ChiNext down 5.71%, and CSI 300 down 2.22%. The brand index fell 3.58% to 1956.62 points [2]. - Notable gainers in the brand index included Shanghai Jahwa up 9.42%, Changbai Mountain up 7.19%, and Darentang up 5.34%. Other stocks like Luzhou Laojiao and Yiling Pharmaceutical also saw gains exceeding 4% [2]. Stock Performance Since H2 - Since the beginning of the second half of the year, Zhongji Xuchuang has surged 156.40%, leading the gains, followed by Sunshine Power at 114.27%. Other significant performers include Lanke Technology and Yiwei Lithium Energy, both up over 60% [3]. Market Outlook - Looking ahead, the market is expected to maintain upward momentum as uncertainties gradually diminish. Liquidity is anticipated to remain supportive, with domestic interest rates low and overseas liquidity remaining loose, encouraging investment in Chinese equity assets [4][5]. - The current market environment is characterized by a shift in investment styles, with a focus on sectors that offer higher investment certainty, particularly in electronics, new energy, new consumption, and real estate [5].

Group 1 - The core index of the Xinhua National Brand Project reported 1956.62 points, with several constituent stocks rising against the market trend [1] - Shanghai Jahwa increased by 9.42%, leading the gains among constituent stocks, followed by Changbaishan at 7.19% and Darentang at 5.34% [1] - The overall market saw declines, with the Shanghai Composite Index down 1.47% and the Shenzhen Component Index down 4.99% [1] Group 2 - Since the second half of the year, Zhongji Xuchuang has risen by 156.40%, ranking first in gains, followed by Sunshine Power at 114.27% [2] - The market is expected to maintain upward momentum, with liquidity driving potential growth and fundamental support gradually increasing [2] - Domestic interest rates remain low, and overseas liquidity is expected to remain loose, indicating continued capital allocation towards Chinese equity assets [2] Group 3 - Recent market adjustments are attributed to a decline in global market risk appetite and a shift in investment style towards defensive sectors [3] - The current market environment is characterized by high levels, increased uncertainty, and a slowdown in previous catalysts, leading to cautious trading [3] - Investors are encouraged to seek opportunities in sectors with higher investment certainty, particularly in electronics, new energy, new consumption, and real estate [3]

Investment Rating - The report maintains a positive outlook on the cosmetics and medical beauty sector, highlighting strong performance relative to the market [5][6]. Core Insights - The Tmall Double 11 event showcased strong sales for domestic brands, with significant demand for products from brands like Maogeping and Winona, indicating a robust market response [9][10]. - The cosmetics and medical beauty sector is expected to see continued growth, with Q3 performance meeting expectations and Q4 anticipated to benefit from promotional activities [10][11]. - The report emphasizes the importance of online channels, particularly Tmall and Douyin, in driving sales for domestic brands, which are gaining market share against international competitors [24][26]. Summary by Sections Industry Performance - The cosmetics and medical beauty sector outperformed the market from October 10 to October 17, 2025, with the Shenwan Beauty Care Index declining by 2.5%, which is better than the overall market performance [5][6]. - Key stocks in the sector included Jiaheng Jiahu (+35.0%), Yiyi Co. (+18.6%), and Yanjing Co. (+15.6%), while Maogeping (-7.2%) and Shangmei Co. (-5.4%) lagged [6]. Sales and Market Trends - The report notes that the overall retail sales of cosmetics in China reached 291.5 billion yuan in the first eight months of 2025, with a year-on-year growth of 3.3% [10][16]. - The Tmall Double 11 event attracted over 10 million viewers, with domestic brands experiencing sell-out conditions, indicating strong consumer interest and demand [9][10]. Company Highlights - Han Shu, a brand under Shangmei Co., has shown significant improvement in Tmall channel performance, collaborating with popular influencers to enhance sales [9][10]. - The report highlights the strategic partnership of Han Shu with global ambassador Wang Jiaer, aiming to elevate the brand's international presence and market perception [20][21]. Investment Recommendations - The report recommends focusing on brands with strong online sales growth, such as Maogeping, Shangmei Co., and Shanghai Jahwa, while also monitoring companies like Proya and Marubi for potential performance improvements [12][13]. - In the medical beauty segment, the report suggests investing in companies with strong R&D capabilities and product pipelines, recommending Aimeike as a key player [12][13].

Investment Rating - The report maintains a "Positive" outlook on the cosmetics and medical beauty industry [2]. Core Views - The cosmetics and medical beauty sector has shown stronger performance than the market, with the Shenwan Beauty Care Index declining by 2.5% from October 10 to October 17, 2025, which is better than the overall market performance [4][5]. - The Tmall Double 11 event has seen significant success for domestic brands, with brands like Maogeping experiencing high demand and sold-out products [10]. - The overall performance for Q3 2025 is expected to meet expectations, with a continued upward trend into Q4, driven by promotional events [11][12]. Summary by Sections Industry Performance - The cosmetics and medical beauty sector outperformed the market during the specified period, with the Shenwan Cosmetics Index down by 1.1%, which is 2.3 percentage points better than the Shenwan A Index [4][5]. - Key stocks in the sector included Jiaheng Jiahua (+35.0%), Yiyi Co. (+18.6%), and Yanjing Co. (+15.6%) [6]. Market Trends - The Tmall Double 11 event on October 15 attracted over 10 million viewers, with domestic brands like Maogeping experiencing supply shortages due to high demand [10]. - The overall sales performance is expected to improve in the coming weeks, particularly with the upcoming Douyin Double 11 event [10]. Q3 Performance Outlook - The demand for cosmetics remains robust, with retail sales growth in July and August outpacing the overall market [11]. - The total retail sales of cosmetics for the first eight months of 2025 reached 291.5 billion yuan, a year-on-year increase of 3.3% [11]. - Domestic brands are leveraging online channels effectively, with Han Shu achieving over 2 billion yuan in GMV in Q3 [12]. Company Highlights - Han Shu announced a global partnership with Wang Jiaer, enhancing its international presence and brand recognition [19][22]. - The report recommends focusing on companies with strong channel and brand matrices, such as Maogeping, Shanghai Jahwa, and Up Beauty [14]. E-commerce Data - The report highlights significant growth in e-commerce sales for various brands, with Han Shu achieving a 37% increase in GMV [15]. - The overall e-commerce landscape for domestic brands is expected to continue thriving, supported by promotional events and strategic partnerships [15][18]. Market Dynamics - The report notes that the Chinese skincare market is projected to reach 271.2 billion yuan in 2024, despite a slight decline in growth [26]. - Domestic brands are increasingly capturing market share, with a notable presence in the top ten rankings [26][27]. Investment Recommendations - The report suggests investing in companies with strong growth potential and robust product pipelines, particularly in the cosmetics and medical beauty sectors [14]. - Specific recommendations include Maogeping, Up Beauty, and Shanghai Jahwa for cosmetics, and Aimeike for medical beauty [14].

Core Insights - The article discusses the transformation of Shanghai Jahwa, a traditional cosmetics company, from performance decline to recovery, highlighting its strategic shift towards supply chain control and innovation [1][4][10] Industry Overview - Shanghai is a major hub for the cosmetics industry in China, with 230 production enterprises and 3,200 registered entities, dominating the import registration market [1] - The industry faces common challenges such as supply chain restructuring, innovation in research and development, and brand rejuvenation [1][4] Company Strategy - Shanghai Jahwa has strategically relocated its production from OEM factories back to its own facilities in Qingpu, reflecting a broader trend in the cosmetics industry to reassess supply chain structures [5][7] - The company increased its R&D investment by 26.3% year-on-year, indicating a commitment to innovation despite overall cost control measures [8] Supply Chain Dynamics - The return of production to Qingpu is not merely a logistical move but signifies a deeper restructuring of the supply chain, focusing on cost efficiency, quality control, and risk management [5][7] - The establishment of a "factory-to-consumer" (C2M) model aims to enhance product freshness, cost optimization, and delivery efficiency, although it poses significant operational challenges [7] R&D and Innovation - Shanghai Jahwa's 35 years of R&D experience and over 400 patents highlight the importance of long-term investment in research as a competitive advantage [8] - The company is focusing on leveraging traditional Chinese medicine in its product development, collaborating with research institutions to modernize and scientifically validate its offerings [8][11] Market Positioning - The rise of domestic brands is not just about market share but involves a systemic reconstruction of technology, cultural confidence, and industry ecology [10][12] - Successful domestic brands are transitioning from "Chinese elements" to "Chinese values," integrating traditional culture with modern consumer needs [11] Industry Collaboration - The Qingpu industrial cluster exemplifies the importance of collaborative innovation, where the efficiency of various industry segments determines overall competitiveness [11][12] - Shanghai Jahwa's willingness to share testing facilities with peers reflects a recognition of the need for collective industry standards to enhance competitiveness on a global scale [11]

Index Performance - The CSI A500 Index decreased by 3.31% this week, closing at 5392.97 points on October 17 [5] - The average daily trading volume for the week was 8521.04 billion yuan, reflecting a 22.20% decrease compared to the previous week [5] Top Performers - The top ten gainers in the CSI A500 index included: 1. Shanghai Pudong Development Bank (600000.SH) with a gain of 12.50% 2. Agricultural Bank of China (601288.SH) with a gain of 11.57% 3. Huatian Technology (002185.SZ) with a gain of 10.02% 4. Shanghai Jahwa United Co., Ltd. (600315.SH) with a gain of 9.42% 5. Hainan Airport (600515.SH) with a gain of 8.96% 6. Shaanxi Coal and Chemical Industry (601225.SH) with a gain of 8.61% 7. Jiangsu Bank (600919.SH) with a gain of 8.60% 8. Tongwei Co., Ltd. (600438.SH) with a gain of 8.31% 9. Air China (601111.SH) with a gain of 7.63% 10. China Pacific Insurance (601319.SH) with a gain of 7.32% [2] Bottom Performers - The top ten losers in the CSI A500 index included: 1. Shengquan Group (605589.SH) with a loss of 18.04% 2. Wentai Technology (600745.SH) with a loss of 17.17% 3. Betta Pharmaceuticals (300558.SZ) with a loss of 16.98% 4. Leo Group (002131.SZ) with a loss of 16.55% 5. Jinlang Technology (300763.SZ) with a loss of 15.40% 6. Tongfu Microelectronics (002156.SZ) with a loss of 14.98% 7. Yake Technology (002409.SZ) with a loss of 14.35% 8. Lens Technology (300433.SZ) with a loss of 14.26% 9. Zhongding Sealing Parts (000887.SZ) with a loss of 13.99% 10. Robot Technology (300757.SZ) with a loss of 13.95% [2] Fund Performance - All 40 CSI A500 ETFs experienced declines, with notable drops in Huatai-PB's CSI A500 Enhanced ETF and Guolian's A500 Enhanced ETF, both falling over 4% [5] - The total scale of the CSI A500 ETFs fell below 200 billion yuan, with Huatai-PB's fund at 249.03 billion yuan, Guotai's at 226.56 billion yuan, and E Fund's at 221.29 billion yuan [5] Market Insights - Pacific Securities research team suggests a balanced allocation towards low-position sectors, particularly banks and insurance with dividend protection attributes, as well as coal and agriculture sectors benefiting from domestic demand recovery [6] - Guohai Securities research team indicates that uncertainties from trade frictions may lead to a rotation in market styles, with a shift from overvalued growth sectors to undervalued sectors [6]

Core Points - Shanghai Jahwa announced a cash dividend of 0.039 CNY per share for the first half of 2025, totaling approximately 26.15 million CNY [2][4] - The dividend distribution plan was approved at the annual shareholders' meeting on June 25, 2025 [2][3] - The dividend will be distributed to all shareholders registered with the China Securities Depository and Clearing Corporation Limited, Shanghai Branch, as of the close of trading on the record date [3] Distribution Plan - The total number of shares eligible for the dividend is 670,621,808 after excluding shares held in the company's repurchase account [4] - The reference price for the ex-dividend calculation is based on the previous closing price minus the virtual cash dividend of approximately 0.03891 CNY per share [5] - The distribution will only involve cash dividends, with no capital reserve conversion or stock issuance, resulting in no change to the circulating shares [5] Implementation Details - Cash dividends for unrestricted circulating shares will be distributed through the clearing system of the China Securities Depository and Clearing Corporation [7] - Shareholders who have not completed designated transactions will have their dividends held by the clearing company until the transactions are completed [7] - The company will directly distribute cash dividends to specific entities, including Shanghai Jahwa (Group) Co., Ltd. and Shanghai Huisheng Industrial Co., Ltd. [8] Taxation Information - Individual shareholders holding unrestricted circulating shares will not have taxes withheld at the time of dividend distribution, with the actual cash dividend being 0.039 CNY per share [8] - For foreign institutional investors (QFII), a 10% withholding tax will apply, resulting in a net cash dividend of 0.0351 CNY per share [9] - Other institutional investors are responsible for their own tax payments, with a gross cash dividend of 0.039 CNY per share [9]

Core Points - Shanghai Jahwa announced a profit distribution plan for the first half of 2025, proposing a cash dividend of 0.039 yuan per share (tax included) for A-shares [2] Summary by Category Profit Distribution - The cash dividend of 0.039 yuan per share is set to be distributed to A-shareholders [2] - The record date for the dividend is October 22, 2025, and the ex-dividend date is October 23, 2025 [2]

国浩律师（上海）事务所 关于上海家化联合股份有限公司 差异化分红事项之专项法律意见书 致：上海家化联合股份有限公司 根据《中华人民共和国公司法》（以下简称"《公司法》"）、《中华人民共和国 证券法》（以下简称"《证券法》"）、《上市公司股份回购规则》（以下简称"《回购 规则》"）、《上海证券交易所上市公司自律监管指引第 7 号——回购股份》（以下 简称"《回购指引》"）、《上海证券交易所股票上市规则》（以下简称"《上市规则》"） 以及《上海家化联合股份有限公司公司章程》（以下简称"《公司章程》"）等相关 法律、法规及规范性文件的规定，本所律师就上海家化联合股份有限公司（以下 简称"公司"）2025 年半年度利润分配涉及的差异化分红特殊除权除息处理（以 下简称"本次差异化分红"）相关事项出具本法律意见书。 国浩律师（上海）事务所 法律意见书 按照律师行业公认的业务标准、道德规范和勤勉尽责的精神，依据本法律意 见书出具日以前已发生或存在的事实，本所律师发表法律意见，并声明如下： 4、本所律师仅就公司本次差异化分红的合法性及相关中国法律问题发表意 见，本所律师在出具本法律意见书时，对与法律相关的业务事项已履行法律专 ...

证券代码：600315 证券简称：上海家化 公告编号：2025-049 上海家化联合股份有限公司 2025年半年度权益分派实施公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗 漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 每股分配比例 2. 分派对象： 截至股权登记日下午上海证券交易所收市后，在中国证券登记结算有限责任公司上海分 公司（以下简称"中国结算上海分公司"）登记在册的本公司全体股东。 A 股每股现金红利0.039元 相关日期 | 股份类别 | 股权登记日 | 最后交易日 | 除权（息）日 | 现金红利发放日 | | --- | --- | --- | --- | --- | | Ａ股 | 2025/10/22 | － | 2025/10/23 | 2025/10/23 | 差异化分红送转： 是 一、 通过分配方案的股东会届次和日期 本次利润分配方案经公司2025 年 6 月 25 日的2024年年度股东会及公司九届三次董事会审议 通过。 二、 分配方案 1. 发放年度：2025年半年度 3. 差异化分红送转方案： （1）差异化利润分配方案 根 ...